Jul 29, 2026 06:30AM
Jul 29, 2026 06:30AM
Jul 27, 2026 06:49AM
Jul 24, 2026 06:35AM
Jul 24, 2026 06:35AM
Jul 24, 2026 06:30AM
Jul 24, 2026 06:30AM MannKind Announces FDA Approval of Furoscix ReadyFlow™, the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for the Treatment of Edema in Adults with Heart Failure or Chronic K
Jun 23, 2026 09:00AM
Jun 23, 2026 09:00AM
Jun 5, 2026 07:35PM
Jun 3, 2026 06:05AM
Jun 3, 2026 06:05AM
May 29, 2026 02:00PM
May 29, 2026 02:00PM MannKind to Host Conference Call Today to Discuss Afrezza Pediatric Approval
May 29, 2026 12:44PM
May 29, 2026 12:30PM
May 29, 2026 12:30PM
May 27, 2026 09:06AM
May 27, 2026 09:05AM
May 6, 2026 06:31AM
May 6, 2026 06:30AM MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases
Mar 9, 2026 09:05AM
Mar 9, 2026 09:05AM
Feb 26, 2026 08:00AM
Feb 9, 2026 06:10AM
Feb 9, 2026 06:05AM
Jan 27, 2026 08:33AM
Jan 26, 2026 06:05AM MannKind receives FDA approval for updated Afrezza dosing guidance
Jan 26, 2026 06:05AM
Jan 23, 2026 12:56PM
Jan 8, 2026 08:08AM
Jan 8, 2026 08:05AM
Dec 23, 2025 08:06AM
Dec 23, 2025 08:05AM
Dec 1, 2025 08:05AM FDA accepts MannKind's application for FUROSCIX ReadyFlow autoinjector
Dec 1, 2025 08:05AM
Nov 5, 2025 08:00AM
Oct 13, 2025 08:05AM
Oct 13, 2025 08:05AM
Sep 3, 2025 06:44AM
Aug 27, 2025 08:06AM
Aug 27, 2025 08:05AM MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy
Aug 25, 2025 07:30AM
Aug 25, 2025 07:30AM
Aug 6, 2025 07:05AM
May 8, 2025 08:05AM
Apr 12, 2025 04:00AM
Mar 10, 2025 06:05AM
Feb 26, 2025 04:05PM MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Dec 16, 2024 06:06AM

327,060 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All